Viral load of human papilloma virus 16 as a determinant for development of cervical carcinoma in situ: a nested case-control study (Q38464569)

3 September 2017

title

Viral load of human papilloma virus 16 as a determinant for development of cervical carcinoma in situ: a nested case-control study (English)

1 reference

3 September 2017

1 reference

human papilloma virus

object named as

human papilloma virus

1 reference

2

1 reference

3 September 2017

7

M Melbye

1 reference

3 September 2017

8

H O Adami

1 reference

3 September 2017

A M Josefsson

1

1 reference

3 September 2017

N Ylitalo

3

1 reference

3 September 2017

P Sørensen

4

1 reference

3 September 2017

P Qwarforth-Tubbin

5

1 reference

3 September 2017

P K Andersen

6

1 reference

3 September 2017

U B Gyllensten

9

1 reference

3 September 2017

language of work or name

English

0 references

publication date

1 June 2000

1 reference

3 September 2017

1 reference

3 September 2017

volume

355

1 reference

3 September 2017

issue

9222

1 reference

3 September 2017

page(s)

2189-2193

1 reference

Estimates of the worldwide incidence of eighteen major cancers in 1985.

3 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2902401-6

7 January 2021

Prevalence of human papillomavirus in cervical cancer: a worldwide perspective. International biological study on cervical cancer (IBSCC) Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2902401-6

7 January 2021

Risk factors for cervical intraepithelial neoplasia: differences between low- and high-grade lesions

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2902401-6

7 January 2021

Human papillomavirus type 16 in cervical smears as predictor of high-grade cervical intraepithelial neoplasia [corrected]

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2902401-6

7 January 2021

Type-specific human papillomavirus DNA in abnormal smears as a predictor of high-grade cervical intraepithelial neoplasia

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2902401-6

7 January 2021

HPV 16 and cigarette smoking as risk factors for high-grade cervical intra-epithelial neoplasia.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2902401-6

7 January 2021

Viral characteristics of human papillomavirus infection and antioxidant levels as risk factors for cervical dysplasia

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2902401-6

7 January 2021

Human papillomavirus testing by hybrid capture appears to be useful in triaging women with a cytologic diagnosis of atypical squamous cells of undetermined significance

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2902401-6

7 January 2021

Definition of human papillomavirus type 16 DNA levels in low and high grade cervical lesions by a simple polymerase chain reaction technique

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2902401-6

7 January 2021

Smoking and oral contraceptives as risk factors for cervical carcinoma in situ

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2902401-6

7 January 2021

Detection and quantitation of human papillomavirus by using the fluorescent 5' exonuclease assay

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2902401-6

7 January 2021

Detection of genital human papillomavirus by single-tube nested PCR and type-specific oligonucleotide hybridization

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2902401-6

7 January 2021

Detection of specific polymerase chain reaction product by utilizing the 5'----3' exonuclease activity of Thermus aquaticus DNA polymerase

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2902401-6

7 January 2021

Real time quantitative PCR

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2902401-6

7 January 2021

Allelic discrimination by nick-translation PCR with fluorogenic probes

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2902401-6

7 January 2021

Epidemiology of Genital Human Papillomavirus Infection

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2902401-6

7 January 2021

Human papillomavirus genotype as a predictor of persistence and development of high-grade lesions in women with minor cervical abnormalities

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2902401-6

7 January 2021

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2902401-6

1 reference

7 January 2021

Susceptibility to human papillomavirus-associated cervical intra-epithelial neoplasia is determined by specific HLA DR-DQ alleles

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2902401-6

7 January 2021

HLA DQ-DR haplotype and susceptibility to cervical carcinoma: indications of increased risk for development of cervical carcinoma in individuals infected with HPV 18

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2902401-6

7 January 2021

Comparison of human leukocyte antigen DR-DQ disease associations found with cervical dysplasia and invasive cervical carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2902401-6

7 January 2021

Natural history of cervicovaginal papillomavirus infection in young women.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2902401-6

7 January 2021

Consistent high viral load of human papillomavirus 16 and risk of cervical carcinoma in situ: a nested case-control study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2902401-6

7 January 2021

10.1016/S0140-6736(00)02401-6

Identifiers

DOI

1 reference

3 September 2017

1 reference